Herbalife’s (NYSE:HLF) Q3 2026 sales beat estimates, stock soars
Herbalife (HLF) reported Q3 2026 revenue of $1.35B, beating estimates by 3.2%, and adjusted EPS of $0.64, exceeding expectations by 3.7%. Adjusted EBITDA was $182.4M, a 7.9% beat. Q4 revenue guidance is $1.32B, in line with estimates, while full-year EBITDA guidance is $680M, above consensus. Operating and free cash flow margins remained steady year-over-year.
How this was made

The 30-second read
Why it matters
The earnings beat and modestly positive guidance are likely to sustain short‑term upside.
Market read
Earnings beat provides a clear catalyst for traders; the stock's rally reflects immediate market reaction.
What to watch
Potential supply‑chain cost pressures not reflected in guidance.
Background
Herbalife is a global nutrition and weight‑loss company listed on NYSE.
Ticker impact
Herbalife reported Q3 2026 revenue and EPS beats, prompting the stock to soar.
likely upward pressure as investors price in the beat and strong guidance.
Revenue and EPS both exceeded consensus, and guidance is in line or slightly above expectations, supporting a rally.
Market effects
Weight loss and nutrition sector may see modest uplift from Herbalife's beat.
U.S. consumer discretionary sentiment boosted.
Limited to investors tracking mid‑cap earnings.
Counterpoint
Some analysts may question sustainability of growth given modest guidance.
Key entities
- CompanyHerbalife Nutrition Ltd.
Subject of the earnings report.





